Abstract
Injection of total saponins from Panax notoginseng (ISPN) is a modern preparation derived from traditional Chinese medicine (TCM) and is widely applied in the treatment of cardiovascular, cerebrovascular, ophthalmology, and endocrine system diseases. With the increase in the clinical application of ISPN, its adverse drug reactions (ADRs) and related safety issues have attracted much attention. In the present study, a data-independent acquisition (DIA) strategy was proposed to comprehensively characterize the saponins contained in ISPN based on the ultra-high-performance liquid chromatography/quadrupole-Orbitrap MS (UHPLC/Q-Orbitrap MS) platform. As many as 276 saponins were detected, and 250 compounds were identified or tentatively identified based on the retention times and MS/MS data. Furthermore, a metabolomic strategy was utilized to discover the discriminative saponins between normal and ADR batches. The results showed that six saponins, including ginsenoside Rh4, ginsenoside Rk3, ginsenoside Rg5, ginsenoside Rk1, ginsenoside Rg6, and 20(S)-ginsenoside Rh2, were significantly different between the two groups. According to cytotoxicity analysis and degranulation detection of RBL-2H3 cells, ginsenoside Rg5, ginsenoside Rk1, and 20(S)-ginsenoside Rh2 were considered the potential compounds responsible for clinical ADRs, ultimately. In addition, the quantitative analysis showed that the content of these three compounds in ISPN samples with ADRs was generally higher than that in samples without ADRs. This study demonstrated that it is advisable to screen out potential markers related to ADRs for developing the quality standard of ISPN by the integration of untargeted metabolomic analysis and cell biology study, and thus reduce its ADRs in the clinic.
Graphical abstract
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request. Original material is also available upon request.
Code availability
MS-DIAL is an open-source software and readily available to the public.
References
Zeng X, Zheng YY, Luo JW, Liu H, Su WW. A review on the chemical profiles, quality control, pharmacokinetic and pharmacological properties of Fufang Xueshuantong Capsule. J Ethnopharmacol. 2021;267:113472.
Zhang HW, Zhang H, Grant SJ, Wan X, Li G. Single herbal medicine for diabetic retinopathy. Cochrane Database Syst Rev. 2018; https://doi.org/10.1002/14651858.CD007939.pub2.
Lyu J, Xie YM, Sun MH, Zhang LD. Efficacy and safety of Xueshuantong injection on acute cerebral infarction: clinical evidence and GRADE assessment. Front Pharmacol. 2020;11:822–37.
Wang HD, Zhang CX, Zuo TT, Li WW, Jia L, Wang XY, et al. In-depth profiling, characterization, and comparison of the ginsenosides among three different parts (the root, stem leaf, and flower bud) of Panax quinquefolius L. by ultra-high performance liquid chromatography/quadrupole-Orbitrap mass spectrometry. Anal Bioanal Chem. 2019;411:7817–29.
Yang WZ, Zhang JX, Yao CL, Qiu S, Chen M, Pan HQ, et al. Method development and application of offline two-dimensional liquid chromatography/quadrupole time-of-flight mass spectrometry-fast data directed analysis for comprehensive characterization of the saponins from Xueshuantong Injection. J Pharm Biomed Anal. 2016;128:322–32.
Yang WZ, Ye M, Qiao X, Liu CF, Miao WJ, Bo T, et al. A strategy for efficient discovery of new natural compounds by integrating orthogonal column chromatography and liquid chromatography/mass spectrometry analysis: its application in Panax ginseng, Panax quinquefolium and Panax notoginseng to characterize 437 potential new ginsenosides. Anal Chim Acta. 2012;739:56–6.
Christensen LP. Ginsenosides: chemistry, biosynthesis, analysis, and potential health effects. Adv Food Nutr Res. 2008;55:1–99.
Wang M, Zhang HJ, Dong RR, Tan LJ, Liu ZD, Zhu Y, et al. Compatible stability study of panax notoginseng saponin injection (xueshuantong®) in combination with 47 different injectables. Biomed Chromatogr. 2016;30:1599–610.
Li CX, Xu T, Zhou P, Zhang JH, Guan G, Zhang H, et al. Post-marketing safety surveillance and reevaluation of Xueshuantong injection. BMC Complement Altern Med. 2018;18:277.
Yang ZR, Wang ZH, Tang JF, Yan Y, Yue SJ, Feng WW, et al. UPLC-QTOF/MSE and bioassay are available approaches for identifying quality fluctuation of Xueshuantong lyophilized powder in clinic. Front Pharmacol. 2018;9:633.
Chinese Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China, Part 1. Beijing, China: Chinese Medical Science and Technology Press; 2020.
Shen MR, He Y, Shi SM. Development of chromatographic technologies for the quality control of traditional Chinese medicine in the Chinese Pharmacopoeia. J Pharm Anal. 2021;11:155–62.
Zhang J, Wu XF, Qiu JQ, Zhang L, Zhang YT, Qiu XH, et al. A comprehensive comparison on chemical profile of GCP at different ripeness stages using untargeted and pseudotargeted metabolomics. J Agric Food Chem. 2020;68:8483–95.
Ch R, Chevallier O, McCarron P, McGrath TF, Wu D, Duy LND, et al. Metabolomic fingerprinting of volatile organic compounds for the geo-graphical discrimination of rice samples from China Vietnam and India. Food Chem. 2021;334:127553.
Guo J, Huan T. Evaluation of significant features discovered from different data acquisition modes in mass spectrometry-based untargeted metabolomics. Anal Chim Acta. 2020;1137:37–46.
Hpirttilä K, Laurell G, Pettersson C, Hedeland M. Automated sequential analysis of hydrophilic and lipophilic fractions of biological samples: increasing single-injection chemical coverage in untargeted metabolomics. Metabolites. 2021;11:295.
Jin YR, Tian TT, Ma YH, Hou LD, Guan S, Sun WJ, et al. Chemical profiling and total quality assessment of Isodon japonica using data-independent acquisition mode combined with superimposed multiple product ion UHPLC-Q-TOF-MS and chemometric analysis. RSC Adv. 2019;9:1403–18.
Fenaille F, Barbier Saint-Hilaire PB, Rousseau K, Junot C. Data acquisition workflows in liquid chromatography coupled to high resolution mass spectrometry-based metabolomics: where do we stand? J Chromatogr A. 2017;1526:1–12.
Zhang WD, Jiang HH, Yang JX, Song GS, Wen D, Liu WQ, et al. A high-throughput metabolomics approach for the comprehensive differentiation of four Pulsatilla Adans herbs combined with a nontargeted bidirectional screen for rapid identification of triterpenoid saponins. Anal Bioanal Chem. 2019;411:2071–88.
Hilaire PBS, Rousseau K, Seyer A, Dechaumet S, Damont A, Junot C, et al. Comparative evaluation of data dependent and data independent acquisition workflows implemented on an Orbitrap fusion for untargeted metabolomics. Metabolites. 2020;10:158.
Guo J, Huan T. Comparison of full-scan, data-dependent, and data-independent acquisition modes in liquid chromatography–mass spectrometry based untargeted metabolomics. Anal Chem. 2020;92:8072–80.
Fernández-Costa C, Martínez-Baé S, McCrtolomlatchy DB, Saviola AJ, Yu NK, Yates JR. Impact of the identification strategy on the reproducibility of the DDA and DIA results. J Proteome Res. 2020;19:3153–61.
Schilling B, MacLean B, Held JM, Sahu AK, Rardin MJ, Sorensen DJ, et al. Multiplexed, scheduled, high-resolution parallel reaction monitoring on a full scan QqTOF instrument with integrated data-dependent and targeted mass spectrometric workflows. Anal Chem. 2015;87:10222–9.
Zhou JT, Li YH, Chen X, Zhong LJ, Yin YX. Development of data-independent acquisition workflows for metabolomic analysis on a quadrupole-orbitrap platform. Talanta. 2017;164:128–36.
Jia W, Shi QY, Shi L, Qin JZ, Chang J, Chu XG. A strategy of untargeted foodomics profiling for dynamic changes during Fu brick tea fermentation using ultrahigh-performance liquid chromatography-high resolution mass spectrometry. J Chromatogr A. 2020;1618:460900.
Sun FF, Tan HG, Li YS, De Boevre M, Zhang HY, Zhou JH, et al. An integrated data-dependent and data-independent acquisition method for hazardous compounds screening in foods using a single UHPLC-Q-Orbitrap run. J Hazard Mater. 2021;401:123266.
Wang RH, Yin YD, Zhu ZJ. Advancing untargeted metabolomics using data-independent acquisition mass spectrometry technology. Anal Bioanal Chem. 2019;411:4349–57.
Tsugawa H, Cajka T, Kind T, Ma Y, Higgins B, Ikeda K, et al. MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis. Nat Methods. 2015;12:523–6.
Lai ZJ, Tsugawa H, Wohlgemuth G, Mehta S, Mueller M, Zheng YX, et al. Identifying metabolites by integrating metabolome databases with mass spectrometry cheminformatics. Nat Methods. 2018;15:53–6.
Tada I, Chaleckis R, Tsugawa H, Meister I, Zhang P, Lazarinis N, et al. Correlation-based deconvolution (CorrDec) to generate high-quality MS2 spectra from data-independent acquisition in multisample studies. Anal Chem. 2020;92:11310–7.
Feng JJ, Yu PF, Zhou Q, Tian ZH, Sun MJ, Li XL, et al. An integrated data filtering and identification strategy for rapid profiling of chemical constituents, with Arnebiae Radix as an example. J Chromatogr A. 2020;1629:461496.
Fu LL, Ding H, Han LF, Jia L, Yang WZ, Zhang CX, et al. Simultaneously targeted and untargeted multicomponent characterization of Erzhi Pill by offline two-dimensional liquid chromatography/quadrupole-Orbitrap mass spectrometry. J Chromatogr A. 2019;1584:87–96.
Huang LF, Pi J, Wu JL, Zhou H, Cai JY, Li T, et al. A rapid and sensitive assay based on particle analysis for cell degranulation detection in basophils and mast cells. Pharmacol Res. 2016;111:374–83.
Shipstone M, Mueller R, Bettenay S, Mason G, Friend S. The use of compound 48/80 as a positive control in equine intradermal allergy testing. Vet Dermatol. 1999;10:291–5.
Hu GZ, Li XQ, Zhang JW, Zhang LJ, Qi J, Yu BY. An integrated strategy for the identification and screening of anti-allergy components from natural products based on calcium fluctuations and cell extraction coupled with HPLC–Q–TOF–MS. Anal Bioanal Chem. 2021. https://doi.org/10.1007/s00216-021-03580-5.
Lee KP, Kang S, Park SJ, Kim JM, Lee JM, Lee AY, et al. Anti-allergic effect of α-cubebenoate isolated from Schisandra chinensis using in vivo and in vitro experiments. J Ethnopharmacol. 2015;173:361–9.
Kang JA, Song HY, Byun EH, Ahn NG, Kim HM, Nam YR, et al. Gamma-irradiated black ginseng extract inhibits mast cell degranulation and suppresses atopic dermatitis-like skin lesions in mice. Food Chem Toxicol. 2018;111:133–43.
Acknowledgements
Many thanks for sampling supportment from The Guangxi Wuzhou Pharmaceutical (Group) Co., Ltd. (Wuzhou, China).
Funding
This study was supported by Important Drug Development Fund, Ministry of Science and Technology of China (2019ZX09201005-002-007), Tianjin Municipal Education Commission Research Project (2017KJ128), and Tianjin Committee of Science and Technology, China (20ZYJDJC00120).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Chenxi Wang and Xu Pang contributed equally to this work.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wang, C., Pang, X., Zhu, T. et al. Rapid discovery of potential ADR compounds from injection of total saponins from Panax notoginseng using data-independent acquisition untargeted metabolomics. Anal Bioanal Chem 414, 1081–1093 (2022). https://doi.org/10.1007/s00216-021-03734-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-021-03734-5